Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for boron neutron capture therapy

Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for boron neutron capture therapy

US Patent 12109269 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for bor2023
Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for bor2023
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same2021
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use2020
Inhalation device and method2019
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same2019
Inhaler and methods of use thereof2019
Polyol estolides and methods of making and using the same2018
Inhalation device and method2018
Processes of preparing estolide compounds that include removing sulfonate residu2017
Polyol estolides and methods of making and using the same2017
Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tet2016